Steven George Hughes, Chief Medical Officer at Avidity Biosciences, Inc. (RNA), sold 162,868 shares at $42.74 ($7.0M) on 2025-08-06, disclosed to the SEC on 2025-08-08.
Scheduled sale ($7.0M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.74 | 6,167 | $264K | 3.8% |
| 2 | $42.74 | 6,167 | $264K | 3.8% |
| 3 | $42.74 | 11,283 | $482K | 6.9% |
| 4 | $42.74 | 11,283 | $482K | 6.9% |
| 5 | $42.74 | 12,334 | $527K | 7.6% |
| 6 | $42.74 | 12,334 |
| $527K |
| 7.6% |
| 7 | $42.74 | 17,667 | $755K | 10.8% |
| 8 | $42.74 | 17,667 | $755K | 10.8% |
| 9 | $42.74 | 33,983 | $1.5M | 20.9% |
| 10 | $42.74 | 33,983 | $1.5M | 20.9% |
| Total | $42.74 avg | 162,868 | $7.0M | 100% |
| Filing → |
| RNA | SELL | 2025-10-24 | $210K | — | Filing → |
| RNA | SELL | 2025-09-23 | $179K | — | Filing → |
| RNA | SELL | 2025-09-17 | $140K | — | Filing → |